Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Debra Ainge

- PMLiVE

Merck’s Keytruda combination recommended by NICE for advanced gastric cancer

More than 6,500 new cases of gastric cancer are diagnosed in the UK every year

- PMLiVE

Study reveals GSK’s new recombinant shingles vaccine could reduce dementia risk

Shingrix reduced dementia diagnoses by 17% compared to Merck & Co’s Zostavax after six years

- PMLiVE

Johnson & Johnson’s Rybrevant recommended by CHMP for pre-treated advanced NSCLC

Non-small lung cancer accounts for up to 85% of all lung cancer cases

- PMLiVE

Creativity at Cannes Lions 2024

Across almost every sector, brands are multiplying their investment in creativity

- PMLiVE

AstraZeneca signs exclusive licensing deal worth over $500m for Pinetree’s EGFR degrader

The candidate has shown promising preclinical anti-tumour activity in drug- and TKI-resistant tumours

- PMLiVE

Pfizer’s one-time haemophilia B gene therapy Durveqtix granted EC approval

More than 42,000 people globally are living with the rare bleeding disorder

- PMLiVE

AbbVie’s IL-23 inhibitor Skyrizi approved by EC to treat ulcerative colitis in adults

The form of inflammatory bowel disease is estimated to affect five million people globally

- PMLiVE

Ipsen gains ex-US rights to Day One’s brain cancer therapy in deal worth over $460m

Paediatric low-grade gliomas are the most common type of brain tumour diagnosed in children

- PMLiVE

Boehringer Ingelheim’s Metalyse recommended by NICE to treat stroke in adults

Ischaemic stroke is responsible for around 85% of all stroke cases in the UK

- PMLiVE

Bayer’s octopus move

The evolutionary lessons for Bayer’s management restructure

- PMLiVE

Danish Agency Twenty Launches New Campaign for F.C. Copenhagen and adidas That Gets International Attention

F.C. Copenhagen and adidas, in collaboration with the Danish agency Twenty, have launched the campaign 'FCK forever,' focusing on a significant health challenge. The campaign serves as a reminder for...

EatMoreFruit

- PMLiVE

Novartis and Dren Bio enter bispecific antibody partnership worth up to $3bn

The companies will aim to advance targeted myeloid engager programmes in oncology

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links